Join
Live feed
·
INSIDERFilingvia Quantisnow
Fennec Pharmaceuticals Inc. logo

Director Raykov Rosty exercised 18,376 shares at a strike of $2.08 and sold $69,753 worth of shares (10,781 units at $6.47) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 121,451 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FENC (Fennec Pharmaceuticals Inc.) and more on Quantisnow.